| scholarly article | Q13442814 |
| P356 | DOI | 10.1289/EHP.7721225 |
| P953 | full work available at URL | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475355 |
| https://europepmc.org/articles/PMC1475355 | ||
| https://europepmc.org/articles/PMC1475355?pdf=render | ||
| P932 | PMC publication ID | 1475355 |
| P698 | PubMed publication ID | 25763 |
| P2093 | author name string | Fiserova-Bergerova V | |
| V. Fiserova-Bergerova | |||
| P2860 | cites work | Drug Metabolism and Disposition | Q1261140 |
| Xenobiotica | Q1360678 | ||
| The role of cytochrome P-450 in the toxicity of fluroxene (2,2,2-trifluoroethyl vinyl ether) anaesthesia in vivo | Q28316246 | ||
| METABOLISM OF VOLATILE ANESTHETICS. | Q35510176 | ||
| Fluroxene toxicity induced by phenobarbital | Q39067378 | ||
| Fluroxene (2,2,2-trifluoroethyl vinyl ether) mediated destruction of cytochrome P-450 in vitro | Q39074218 | ||
| Sex differences in anaesthetic toxicity: fluroxene and trifluoroethanol in mice | Q39096328 | ||
| The interaction of hepatic microsomal cytochrome P-450 with fluroxene (2,2,2-trifluoroethyl vinyl ether) in vitro | Q39102183 | ||
| In vitro studies on irreversible binding of halothane metabolite to microsomes | Q40308595 | ||
| Toxic actions of the metabolites of halothane: LD 50 and some metabolic effects of trifluoroethanol and trifluoroacetic acid in mice and guinea pigs | Q46397447 | ||
| Biotransformation of fluroxene in man. | Q52723700 | ||
| Massive lethal hepatic necrosis in rats anesthetized with fluroxene, after microsomal enzyme induction. | Q52727118 | ||
| Case history number 75: hepatic damage after fluroxene anesthesia. | Q52727668 | ||
| Hepatorenal toxicity following fluroxene anesthesia. | Q52729476 | ||
| Modification of fluroxene toxicity. | Q52730500 | ||
| The toxicity of fluroxene in animals and man. | Q52730866 | ||
| Trifluoroacetic acid and some possible intermediate metabolites of halothane as haptens. | Q52731176 | ||
| Fluroxene toxicity in mice. | Q52732800 | ||
| Jaundice following fluroxene anesthesia. | Q52733168 | ||
| Massive hepatic necrosis after fluroxene anesthesia--a case of drug interaction? | Q52735024 | ||
| Decrease in reduced glutathione and NADPH and inhibition of glucose-6-phosphate dehydrogenase activity caused by metabolites of fluroxene and halothane. | Q52740125 | ||
| A note on the biotransformation of fluroxene in two volunteers. | Q52742140 | ||
| Anesthesia LXXIV: Biotransformation of fluroxene—I. Metabolism in mice and dogs in vivo | Q52756127 | ||
| Blood levels and cardiovascular dynamics during fluroxene anaesthesia in dogs. | Q52758544 | ||
| Anesthesia. XL. The anesthetic action of trifluoroethyl vinyl ether. | Q52778438 | ||
| Fluroxene toxicity in dogs: possible mechanisms | Q70053992 | ||
| A possible mechanism of toxicity of trifluoroethanol and other halothane metabolites | Q71739649 | ||
| Animal toxicity of 2,2,2-trifluoroethanol | Q72465937 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 225-230 | |
| P577 | publication date | 1977-12-01 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | Metabolism and toxicity of 2,2,2-trifluoroethyl vinyl ether | |
| P478 | volume | 21 |
| Q51851619 | Acute toxicity of fluorinated ether anesthetics: Role of 2,2,2-trifluoroethanol and other metabolites |
| Q30677366 | Atmospheric chemistry and environmental assessment of inhalational fluroxene |
| Q39472610 | Multiple aspects of the toxicity of fluroxene and its metabolite 2,2,2-trifluoroethanol |
| Q42241126 | Role of hepatic microsomal cytochrome P-450 in the toxicity of fluorinated ether anesthetics |
| Q72420950 | The role of cytochrome P-450-inducing agents in potentiating the toxicity of fluroxene (2,2,2-trifluoroethyl vinyl ether) |
Search more.